CLINICAL_TRIALS
trial_result
· 2012-05-25
Clinical Trial Update: A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes [Phase 1]
Summary
A Phase 1 dose-escalation study of LY2409021 in participants with type 2 diabetes mellitus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED